What is Pancreatic Cancer?

Pancreatic cancer begins when abnormal cells develop in the tissues of the pancreas. The pancreas lies behind the stomach and produces digestive enzymes and hormones that help regulate blood glucose.

Most pancreatic cancers arise from exocrine cells, which produce digestive enzymes. Pancreatic ductal adenocarcinoma is the most common exocrine pancreatic cancer. Pancreatic neuroendocrine tumours develop from hormone-producing cells and differ in their behaviour, staging and treatment.

Types of Pancreatic Cancer

The types of pancreatic cancer are:

  1. Pancreatic Ductal Adenocarcinoma Pancreatic ductal adenocarcinoma begins in the cells lining the pancreatic ducts. It is the most common pancreatic cancer and may develop in the head, body or tail of the pancreas.

  2. Other Exocrine Pancreatic CancersLess common exocrine cancers include acinar cell carcinoma, adenosquamous carcinoma and other rare tumour types. Their treatment may differ depending on the microscopic findings and disease stage.

  3. Pancreatic Neuroendocrine Tumours Pancreatic neuroendocrine tumours develop from hormone-producing cells. They may produce excess hormones or remain non-functioning. These tumours should be discussed separately because they are biologically different from pancreatic ductal adenocarcinoma.

Stages of Pancreatic Cancer

Pancreatic cancer is classified into stages according to the tumour's size, lymph-node involvement and spread to distant organs. These stages are mentioned below:

Stage Feature
Stage 0 Abnormal cells are limited to the innermost pancreatic duct lining. They have not invaded deeper tissues or spread elsewhere.
Stage I The tumour is confined to the pancreas and has not spread to nearby lymph nodes or distant organs. Stage IA tumours are up to 2 cm, while Stage IB tumours are larger than 2 cm and up to 4 cm.
Stage II The tumour may be larger than 4 cm or may have spread to up to three nearby lymph nodes. It has not spread to distant organs.
Stage III The cancer may involve four or more nearby lymph nodes or grow into major nearby blood vessels. Distant metastasis is absent at this stage.
Stage IV Cancer has spread to distant organs or sites, commonly including the liver, lungs, peritoneum or bones.

How Common is Pancreatic Cancer in India?

Pancreatic cancer is relatively uncommon in India compared to other more frequently diagnosed cancers, like breast cancer and oral cancer. However, its high mortality and tendency to be diagnosed at an advanced stage make it clinically important.

As per the India factsheet on Global Cancer Observatory, India recorded approximately 20,477 new pancreatic cancer cases in 2024, along with 19,953 deaths. The 5-year prevalence of the disease was approximately 1.6 per 1,00,000 population for both sexes combined. Nationwide Indian registry data specific to pancreatic cancer remain limited.

Symptoms of Pancreatic Cancer

Pancreatic cancer may cause few or no noticeable symptoms during its early stages. Symptoms vary according to the tumour’s location and whether it has affected the bile duct, the digestive system, or nearby organs.

The table below lists some of the early warning symptoms and advanced stage symptoms of pancreatic cancer:

Early Warning Signs Advanced Stage Symptoms
  • Persistent upper abdominal discomfort

  • Pain spreading towards the back

  • Loss of appetite

  • Unexplained weight loss

  • Indigestion, bloating or altered stools

  • New-onset or worsening diabetes

  • Jaundice, dark urine or pale stools

  • Persistent fatigue

  • Increasing or severe abdominal or back pain

  • Marked weight and muscle loss

  • Persistent nausea or vomiting

  • Severe weakness and fatigue

  • Abdominal swelling caused by ascites

  • Blood clots, including swelling or pain in a limb

  • Increasing difficulty eating or digesting food

Diseases Similar to Pancreatic Cancer

Several diseases involving the pancreas, bile ducts and nearby abdominal organs can cause overlapping symptoms. Jaundice, abdominal discomfort, weight loss and digestive changes may occur in more than one condition. However, their anatomical origin, progression and treatment differ.

The table below gives a comparative overview of such conditions and their critical features for better understanding:

Pancreatic Cancer Vs. Cholangiocarcinoma Vs. Gallbladder Cancer

Feature Pancreatic Cancer Cholangiocarcinoma Gallbladder Cancer
How It Happens Abnormal cells in the pancreas grow uncontrollably and form a malignant tumour Malignant cells develop in the bile ducts Malignant cells develop in the gallbladder lining
Location Pancreas, commonly the pancreatic head Bile ducts inside or outside the liver Gallbladder
Associated Symptoms Abdominal or back pain, weight loss, jaundice, digestive problems and diabetes changes Jaundice, itching, abdominal pain, fever and weight loss Abdominal pain, jaundice, nausea, weight loss and digestive symptoms
Severity Potentially life-threatening and often diagnosed at an advanced stage Potentially aggressive, with prognosis depending on location and stage Can become aggressive when diagnosed after local or distant spread
Can It Be Reversed? Some localised tumours can potentially be cured with complete surgical removal and appropriate additional treatment Selected localised cancers may be treated with curative-intent surgery Selected localised cancers may be treated with curative-intent surgery

Causes of Pancreatic Cancer

The exact cause of pancreatic cancer is not always known. The disease develops when genetic changes cause pancreatic cells to grow and divide abnormally.

Some of the factors that increase the risk of developing pancreatic cancer are listed below:

  • Tobacco Use: Cigarette smoking is an established modifiable risk factor for pancreatic cancer.

  • Increasing Age: Pancreatic cancer occurs more frequently in older adults, although younger people can also develop it.

  • Chronic Pancreatitis: Long-term inflammation and scarring of the pancreas are associated with an increased risk.

  • Family History: Risk may be higher when close relatives have had pancreatic cancer.

  • Inherited Gene Changes: Variants involving genes may increase susceptibility.

  • Obesity: Excess body weight is associated with a higher risk of pancreatic cancer.

  • Diabetes: Long-standing diabetes is associated with pancreatic cancer, while new-onset diabetes may occasionally be an early consequence of the disease.

Complications of Pancreatic Cancer

Pancreatic cancer and its treatment may cause complications by blocking nearby structures, reducing pancreatic function or spreading to other parts of the body. Some of the complications associated with pancreatic cancer are:

  • Jaundice: A tumour may obstruct the bile duct, causing yellowing of the skin and eyes, itching, dark urine and pale stools.

  • Pain: Tumour growth may press on nearby nerves and organs, causing persistent upper abdominal or back pain.

  • Weight Loss and Malnutrition: Reduced appetite, treatment side effects and poor nutrient absorption can cause significant weight and muscle loss.

  • Pancreatic Exocrine Insufficiency: Reduced production of digestive enzymes may cause bloating, diarrhoea, oily stools, and malabsorption.

  • Diabetes: Damage to insulin-producing pancreatic cells may cause new diabetes or make existing diabetes more difficult to manage.

  • Bile-Duct or Intestinal Obstruction: Tumour growth may block bile flow or prevent food from passing normally through the stomach and small intestine.

  • Blood Clots: Pancreatic cancer increases the risk of deep vein thrombosis and pulmonary embolism.

  • Ascites: Advanced cancer may cause fluid to collect inside the abdomen.

  • Metastasis: Pancreatic cancer commonly spreads to the liver, peritoneum, lungs or other sites.

When Should You See a Healthcare Provider?

It is highly recommended to see a qualified healthcare provider if you develop any or multiple of the following symptoms:

  • Persistent upper abdominal or back pain

  • Unexplained weight loss

  • Loss of appetite

  • Yellowing of the skin or eyes

  • Dark urine or pale stools

  • Persistent vomiting

  • New-onset diabetes without a clear explanation

  • Existing diabetes that suddenly becomes difficult to control

  • Ongoing digestive problems or oily stools

  • Unexplained weakness or fatigue

How is Pancreatic Cancer Diagnosed?

Diagnosis of pancreatic cancer usually combines clinical assessment, imaging, blood tests and tissue examination. A brief overview is provided below:

Diagnostic Overview Table

Test Purpose What the Doctor Detects
Medical History and Physical Examination To assess symptoms, risk factors and general health Jaundice, abdominal tenderness, weight loss, an enlarged gallbladder, diabetes changes and relevant family history
Blood Tests To evaluate liver function, blood glucose and overall health Raised bilirubin, abnormal liver-function results, diabetes and other changes caused by bile-duct obstruction or illness
CA 19-9 Test To support treatment monitoring in selected patients Raised tumour-marker levels that may indicate disease activity, although the test cannot diagnose pancreatic cancer alone
Pancreatic-Protocol CT Scan To locate and stage the tumour Tumour size and location, blood-vessel involvement, enlarged lymph nodes and spread to distant organs
MRI and MRCP To examine the pancreas, liver, pancreatic duct and bile ducts in detail Small tumours, duct obstruction, liver lesions and abnormalities not clearly visible on CT
Endoscopic Ultrasound To obtain detailed images from close to the pancreas Small pancreatic tumours, nearby lymph-node involvement and the relationship of the tumour to surrounding structures
Biopsy To confirm whether a suspicious growth is cancerous Malignant cells, cancer type and other microscopic features of the tumour
Genetic and Molecular Testing To identify inherited or tumour-specific genetic changes Variants such as BRCA1, BRCA2 or other biomarkers that may influence treatment and family counselling
Staging Laparoscopy To look for small areas where cancer has spread that may not appear on scans Cancer deposits in the abdominal cavity or liver that may affect whether surgery is suitable

How is Pancreatic Cancer Managed or Treated?

Pancreatic cancer treatment depends on the stage, place and overall location. Care should be planned by a multidisciplinary team that may include surgical, medical, and radiation oncologists, gastroenterologists, radiologists, pathologists, dietitians, and palliative care specialists.

Common treatment approaches for pancreatic cancer may include:

  1. Surgery

    Surgery offers the main possibility of long-term disease control when the tumour can be completely removed.

    • Whipple Procedure: Commonly used for tumours in the head of the pancreas.
    • Distal Pancreatectomy: Used for selected tumours in the body or tail of the pancreas, usually with removal of the spleen.
    • Total Pancreatectomy: Removes the entire pancreas and is reserved for selected cases.

    Surgery is generally not appropriate when cancer has spread to distant organs. Borderline resectable tumours may receive chemotherapy before surgery.

  2. Chemotherapy Chemotherapy may be given before surgery, after surgery or as the main treatment for locally advanced, metastatic or recurrent disease. The regimen depends on fitness, previous treatment, organ function and treatment goals.

  3. Radiotherapy Radiotherapy may be considered in selected patients with borderline resectable or locally advanced disease, often with chemotherapy. It is not required for every patient.

  4. Targeted Therapy and Immunotherapy Targeted therapy or immunotherapy may be considered when testing identifies a relevant biomarker. These treatments benefit only a small proportion of pancreatic cancer patients and should not be described as routine treatment for everyone.

  5. Supportive and Palliative Care Supportive care may include bile duct stenting, pain management, pancreatic enzyme replacement, nutritional care, diabetes management, anti-sickness medicines, and palliative care. These measures can be provided alongside active cancer treatment.

Common Medicines Used to Treat Pancreatic Cancer

Medicines form an important part of pancreatic cancer treatment, particularly when surgery is not possible or when chemotherapy is needed before or after surgery. The choice depends on cancer stage, resectability, overall health and molecular test results. Medicines may control or reduce the cancer, but they do not replace potentially curative surgery in patients who are suitable for complete tumour removal.

Common medications that may be prescribed by doctors for pancreatic cancer treatment may include:

  • Gemcitabine: Gemcitabine may be used alone or with other medicines to treat pancreatic cancer. It can help slow cancer growth and may be used after surgery or for advanced disease.

  • Nab-paclitaxel: Nab-paclitaxel may be combined with gemcitabine for some patients with advanced pancreatic cancer. This combination can help control tumour growth and disease progression.

  • Fluorouracil (5-FU): Fluorouracil is used in combination chemotherapy regimens for pancreatic cancer. It can be given as part of treatment before or after surgery or for advanced disease.

  • Oxaliplatin: Oxaliplatin is one component of FOLFIRINOX, a multi-medicine chemotherapy regimen used in suitable patients.

  • Irinotecan: Irinotecan is another component of FOLFIRINOX. It may also be used in other specialist-selected regimens.

  • Folinic Acid: Folinic acid, also called leucovorin, is given with fluorouracil as part of FOLFIRINOX and related regimens.

  • Capecitabine: Capecitabine is an oral medicine that can be used in selected chemotherapy regimens. It may be used after surgery or alongside other treatments, depending on the treatment plan.

  • Olaparib: Olaparib may be used as maintenance treatment in selected patients with metastatic pancreatic cancer who have specific inherited BRCA1 or BRCA2 mutations and whose disease has not progressed after platinum chemotherapy.

Note: Cancer medicines require specialist prescriptions and monitoring. The dose and combination depend on the patient's cancer stage, treatment response, organ function and overall health. These medicines should not be started or stopped without the treating oncologist's advice.

Living with Pancreatic Cancer: Daily Challenges and Caregiving

Living with pancreatic cancer may involve repeated hospital visits, chemotherapy, surgery, nutritional support and regular monitoring. Individualised supportive care can help manage symptoms and maintain quality of life.

Some of the commonly faced challenges and essential care points during pancreatic cancer treatment and recovery may include:

  1. Challenges
    • Nutrition and Weight Management: Poor appetite, nausea and reduced enzyme production may make it difficult to maintain adequate nutrition.
    • Digestive Problems: Reduced pancreatic enzyme production can cause malabsorption, bloating or changes in stools. Pancreatic enzyme replacement may help selected patients digest and absorb nutrients.
    • Fatigue and Pain: Cancer-related fatigue and abdominal or back pain can interfere with work, mobility and daily activities. Pain management and supportive care should be discussed with the treating team.
  2. Caregiving and Patient Safety
    • Nutritional Support: A dietitian may recommend smaller meals, adequate protein and prescribed pancreatic enzyme replacement.
    • Symptom Control: Pain, nausea, jaundice, diabetes and digestive symptoms should be discussed promptly with the treating team.
    • Emotional Support: Counselling, caregiver support and palliative care can help patients and families cope with anxiety, uncertainty and treatment fatigue.
    • Regular Monitoring: Follow-up may involve clinical reviews, blood tests and imaging to assess treatment response and complications.
  3. Expenses
    • Cancer Treatment: Surgery, chemotherapy, radiotherapy and hospitalisation may generate substantial one-time or recurring expenses.
    • Medicines and Supportive Care: Costs may include anti-sickness medicines, pain treatment, pancreatic enzymes, diabetes treatment and nutritional supplements.
    • Travel and Accommodation: Repeated visits to tertiary cancer centres may add transport, food and accommodation costs and may lead to loss of income.

What is the Prognosis of Pancreatic Cancer?

The prognosis of pancreatic cancer depends mainly on whether the tumour is localised and can be completely removed, whether lymph nodes or distant organs are involved, the response to systemic therapy and the patient’s overall health.

Localised resectable pancreatic cancer has the best possibility of long-term control, although recurrence can still occur. Locally advanced and metastatic disease is generally treated to control cancer, relieve symptoms and prolong survival rather than provide a surgical cure.

How Can I Prevent Pancreatic Cancer?

Not every case of pancreatic cancer can be prevented. However, certain measures may reduce risk:

  • Avoid smoking and other tobacco products.

  • Maintain a healthy body weight.

  • Remain physically active.

  • Follow a balanced diet containing vegetables, fruit, whole grains and appropriate protein sources.

  • Limit alcohol intake, particularly because heavy alcohol use may contribute to pancreatitis.

  • Obtain medical care for chronic pancreatitis and diabetes.

  • Discuss genetic counselling when several close relatives have had pancreatic cancer or a relevant inherited cancer syndrome is known.

Routine pancreatic cancer screening is not recommended for the average-risk population. People with a strong family history or recognised inherited susceptibility may be offered specialist surveillance using MRI, MRCP or endoscopic ultrasound.

Pancreatic Cancer Treatment Cost in India

Pancreatic cancer treatment costs can vary substantially because treatment may involve surgery, chemotherapy, radiation therapy or combinations of these. The estimated surgery cost for pancreatic cancer is around ₹2 lakh to ₹8 lakh, depending on the surgery type and complications. Additional chemotherapy, diagnostic, hospitalisation, and supportive care expenses may increase the overall treatment cost.

An overview of pancreatic cancer treatment costs in India is given in the table below:

Treatment Component Approximate Cost
Oncologist Consultation ₹600 - ₹3,500 per consultation
CT or MRI for Diagnosis and Staging ₹5,000 - ₹20,000 per scan
Endoscopic Ultrasound With Biopsy ₹8,000 - ₹32,000 per procedure
Whipple Surgery or Other Major Pancreatic Surgery ₹1,50,000 - ₹9,00,000 per admission
Laparoscopic Pancreatic Surgery ₹2,00,000 - ₹5,00,000
Chemotherapy ₹8,000 - ₹1,00,000+ per cycle
Radiotherapy ₹1,20,000 - ₹5,00,000 for a complete course

Note: These are indicative costs and actual expenses may vary by hospital, city, treatment plan, cancer stage, medicines, complications and duration of care.

Does Health Insurance Cover Pancreatic Cancer?

Yes. Most health insurance policies in India provide coverage for pancreatic cancer treatment, depending on the policy terms and conditions. The insurance coverage may include treatment expenses, room charges, attendant care, chemotherapy, radiation therapy, blood tests and physical examination. However, the coverage, waiting periods, exclusions and claim procedures vary among insurers. Reviewing policy documents carefully is advised.

A critical illness insurance policy or a cancer insurance policy can be useful for pancreatic cancer treatment, as it provides a lump sum payment when the disease is diagnosed. However, a waiting period of up to 90 days may apply before a claim can be filed.

How Much Health Insurance Coverage is Needed for Pancreatic Cancer Treatment?

Health insurance coverage amount for pancreatic cancer depends on the level of treatment, the stage at which medical care is provided, the hospital type and surgical assistance. In India, overall treatment costs can range widely from a few lakhs for early-stage treatment to ₹15 - 30 lakh or more for advanced or extensive care.

A mediclaim policy of ₹25–50 lakh is often considered more suitable for specialised care, chemotherapy and advanced surgeries for pancreatic cancer. However, if there are other complications or pre-existing conditions, a coverage of ₹50 lakh to ₹1 crore or a combination of base health insurance plus a top up insurance policy can be beneficial.

FAQs

  • Q1. What is pancreatic cancer?

    Ans: Pancreatic cancer is a disease in which abnormal pancreatic cells grow uncontrollably and form a malignant tumour.
  • Q2. What causes pancreatic cancer?

    Ans: The exact cause of pancreatic cancer is often unknown, but smoking, chronic pancreatitis, obesity, diabetes, family history and inherited gene changes may increase the risk of the disease.
  • Q3. What are the early symptoms of pancreatic cancer?

    Ans: Pancreatic cancer may cause upper abdominal discomfort, back pain, appetite loss, weight loss, jaundice or new-onset diabetes, although early symptoms may be absent.
  • Q4. Is pancreatic cancer curable?

    Ans: Pancreatic cancer may be treated with curative intent when it is localised and can be completely removed surgically, usually with systemic therapy.
  • Q5. How is pancreatic cancer diagnosed?

    Ans: Pancreatic cancer is diagnosed using clinical assessment, blood tests, pancreatic-protocol CT, MRI, endoscopic ultrasound and biopsy when required.
  • Q6. Does pancreatic cancer cause diabetes?

    Ans: Yes. Pancreatic cancer can cause new-onset diabetes or make existing diabetes more difficult to control.
  • Q7. What is the most common symptom of pancreatic cancer?

    Ans: Pancreatic cancer has no single symptom in every patient. Common symptoms include abdominal or back pain, jaundice and unexplained weight loss.
  • Q8. Can pancreatic cancer spread to other organs?

    Ans: Advanced pancreatic cancer commonly spreads to the liver, peritoneum, lungs and distant lymph nodes.
  • Q9. What treatments are available for pancreatic cancer?

    Ans: Pancreatic cancer treatment may include surgery, chemotherapy, selected radiotherapy, biomarker-directed treatment and supportive care.
  • Q10. Can pancreatic cancer be prevented?

    Ans: Pancreatic cancer cannot always be prevented, but avoiding tobacco, maintaining a healthy weight and managing chronic health conditions may reduce risk.
  • Q11. Is pancreatic cancer hereditary?

    Ans: Some pancreatic cancer cases are associated with inherited gene changes or a strong family history.
  • Q12. Is screening available for pancreatic cancer?

    Ans: Routine pancreatic cancer screening is not recommended for average-risk adults. Specialist surveillance may be offered to selected high-risk individuals.
  • Q13. Does health insurance cover pancreatic cancer treatment?

    Ans: Pancreatic cancer treatments are covered under health insurance plans in India, subject to waiting periods, exclusions, sub-limits and other policy conditions.
  • Q14. Can younger people get pancreatic cancer?

    Ans: Yes. Pancreatic cancer can affect younger adults, although it is more frequently diagnosed in older people.
  • Q15. What is the main goal of pancreatic cancer treatment?

    Ans: The goal of pancreatic cancer treatment is to remove the cancer when possible or otherwise control its growth, relieve symptoms, prevent complications and maintain quality of life.
  • References

    • https://www.cancer.gov/types/pancreatic/patient/pancreatic-treatment-pdq

    • https://www.cancer.gov/types/pancreatic/hp/pancreatic-treatment-pdq

    • https://www.icmr.gov.in/icmrobject/custom_data/pdf/resource-guidelines/consensu_3.pd

    • https://www.cancer.gov/types/pancreatic/hp/pancreatic-treatment-pdq

    • https://www.pacehospital.com/pancreatic-cancer-treatment

    • https://www.yashodahospitals.com/procedure-cost/biopsy-test-cost-in-india/

    • https://www.apollohospitals.com/procedures/laparoscopic-pancreatic-surgery

    • https://www.apollohospitals.com/procedures/endoscopic-ultrasound-eus

    • https://www.yashodahospitals.com/procedure-cost/whipple-surgery-cost-in-india/

    • https://www.yashodahospitals.com/kolkata/procedure-cost/chemotherapy/

Other Health Disease Pages